{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:31:55Z","timestamp":1776090715526,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":77,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004044.pub3","type":"reference-entry","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T14:07:37Z","timestamp":1385474857000},"source":"Crossref","is-referenced-by-count":12,"title":["Pharmacological treatment for psychotic depression"],"prefix":"10.1002","author":[{"given":"Jaap","family":"Wijkstra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Lijmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibert","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Geddes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem A","family":"Nolen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,11,26]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD004044.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1176\/ajp.147.9.1203","article-title":"Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression","volume":"147","author":"Anton","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004044.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-0327(93)90041-H","article-title":"Response of psychotic depression subtypes to pharmacotherapy","volume":"28","author":"Anton","year":"1993","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub3-BIB4|cit3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-2007-979200","article-title":"Depressed in-patients respond differently to imipramine and mirtazapine","volume":"32","author":"Bruijn","year":"1999","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub3-BIB3|cit4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02246131","article-title":"A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients","volume":"127","author":"Bruijn","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD004044.pub3-BIB5|cit5","doi-asserted-by":"crossref","unstructured":"Andreescu C Mulsant BH Peasley-Miklus C Rothschild AJ Flint AJ Heo M Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features Journal of Clinical Psychiatry 2007 194 200","DOI":"10.4088\/JCP.v68n0203"},{"key":"10.1002\/14651858.CD004044.pub3-BIB6|cit6","doi-asserted-by":"crossref","unstructured":"Blumberger DM Mulsant BH Emeremni C Houck P Andreescu C Mazumdar S Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial Journal of Psychiatric Research 2011 896 901","DOI":"10.1016\/j.jpsychires.2011.01.003"},{"key":"10.1002\/14651858.CD004044.pub3-BIB7|cit7","first-page":"No. 63D","article-title":"Challenges in conducting a pharmacotherapy study in psychotic depression","author":"Flint","year":"2004","journal-title":"157th Annual Meeting of the American Psychiatric Association; 2004 May 1-6; New York, NY"},{"key":"10.1002\/14651858.CD004044.pub3-BIB8|cit8","unstructured":"Meyers B Rothschild A Gabriele M English J McShea M Kamara T Effectiveness of Selective Serotonin Reuptake Inhibitors Combined With Antipsychotic Medication for the Treatment of Psychotic Depression [STOP-PD; NCT00056472] ClinicalTrials.gov [http:\/\/www.clinicaltrials.gov] 2004"},{"key":"10.1002\/14651858.CD004044.pub3-BIB11|cit9","first-page":"83","article-title":"Diagnosis and treatment of psychosis in geriatric major depression","author":"Meyers","year":"2006","journal-title":"46th Annual NCDEU (New Clinical Drug Evaluation Unit) Meeting; 2006 June 12 - 15; Boca Raton, FL"},{"key":"10.1002\/14651858.CD004044.pub3-BIB9|cit10","doi-asserted-by":"crossref","unstructured":"Meyers BS Flint AJ Rothschild AJ Mulsant BH Whyte EM Peasley-Miklus C A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD) Archives of General Psychiatry 2009 838 47","DOI":"10.1001\/archgenpsychiatry.2009.79"},{"issue":"6","key":"10.1002\/14651858.CD004044.pub3-BIB10|cit11","first-page":"625","article-title":"Errors in Table in: A Double-blind Randomized Controlled Trial of Olanzapine Plus Sertraline vs Olanzapine Plus Placebo for Psychotic Depression: the Study of Pharmacotherapy of Psychotic Depression (STOP-PD)","volume":"68","author":"Meyers","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1521\/suli.2008.38.4.403","article-title":"Correlates of suicidality among patients with psychotic depression","volume":"38","author":"Schaffer","year":"2008","journal-title":"Suicide and Life-Threatening Behavior"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.psychres.2012.02.015","article-title":"Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression","volume":"197","author":"Weissman","year":"2012","journal-title":"Psychiatry Research"},{"issue":"8","key":"10.1002\/14651858.CD004044.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4088\/JCP.v62n0804","article-title":"A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life","volume":"62","author":"Mulsant","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub3-BIB15|cit15","doi-asserted-by":"crossref","unstructured":"Rothschild AJ Williamson DJ Tohen MF Schatzberg A Andersen SW Van Campen LE A double-blind, randomized study of olanzapine and olanzapine\/fluoxetine combination for major depression with psychotic features Journal of Clinical Psychopharmacology 2004 365 73","DOI":"10.1097\/01.jcp.0000130557.08996.7a"},{"key":"10.1002\/14651858.CD004044.pub3-BIB16|cit16","first-page":"NR549","article-title":"Olanzapine-fluoxetine combination for difficult-to-treat depression","author":"Williamson","year":"2001","journal-title":"154th Annual Meeting of the American Psychiatric Association; 2001 May 5-10; New Orleans; LA"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/01.jcp.0000130557.08996.7a","article-title":"A double-blind, randomized study of olanzapine and olanzapine\/fluoxetine combination for major depression with psychotic features","volume":"24","author":"Rothschild","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004044.pub3-BIB18|cit18","first-page":"NR549","article-title":"Olanzapine-fluoxetine combination for difficult-to-treat depression","author":"Williamson","year":"2001","journal-title":"154th Annual Meeting of the American Psychiatric Association; 2001 May 5-10; New Orleans; LA"},{"issue":"6","key":"10.1002\/14651858.CD004044.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00004714-198612000-00003","article-title":"The pharmacological treatment of delusional depression: part II","volume":"6","author":"Spiker","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub3-BIB20|cit20","first-page":"184","article-title":"Pharmacological treatment of delusional depressives","volume":"18","author":"Spiker","year":"1982","journal-title":"Psychopharmacology bulletin"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1176\/ajp.142.4.430","article-title":"The pharmacological treatment of delusional depression","volume":"142","author":"Spiker","year":"1985","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004044.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-0327(88)90067-5","article-title":"Placebo response rates in psychotic and nonpsychotic depression","volume":"14","author":"Spiker","year":"1988","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD004044.pub3-BIB23|cit23","doi-asserted-by":"crossref","unstructured":"van den Broek WW Birkenh\u00e4ger TK Mulder PG Bruijn J Moleman P A double blind study comparing imipramine with fluvoxamine in depressed inpatients Psychopharmacology 2004 481 6","DOI":"10.1007\/s00213-004-1853-3"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-0447.2009.01464.x","article-title":"Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine","volume":"121","author":"Wijkstra","year":"2010","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"12","key":"10.1002\/14651858.CD004044.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1176\/ajp.153.12.1631","article-title":"Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression","volume":"153","author":"Zanardi","year":"1996","journal-title":"American Journal of Psychiatry."},{"issue":"1","key":"10.1002\/14651858.CD004044.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4088\/JCP.v61n0107","article-title":"Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study","volume":"61","author":"Zanardi","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004044.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00004714-200110000-00009","article-title":"Rapid reversal of psychotic depression using mifepristone","volume":"21","author":"Belanoff","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004044.pub3-BIB28|cit28","first-page":"32","article-title":"A double blind study with fluvoxamine vs. desipramine combined with placebo or haloperidol in delusional depression","volume":"9","author":"Bellini","year":"1994","journal-title":"Critical Issues in the Treatment of Affective Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004044.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cct.2009.10.001","article-title":"Corrigendum to 'A Multisite Trial of Mifepristone for the Treatment of Psychotic Depression: A Site-by-Treatment Interaction' [Contemp. Clin. Trials 30 (2009) 284-288] (DOI:10.1016\/j.cct.2009.03.001)","volume":"31","author":"Blasey","year":"2010","journal-title":"Contemporary clinical trials"},{"issue":"5","key":"10.1002\/14651858.CD004044.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cct.2009.06.010","article-title":"Corrigendum to 'A Multisite Trial of Mifepristone for the Treatment of Psychotic Depression: A Site-by-Treatment Interaction' [Contemp. Clin. Trials 30 (2009)284-288] (DOI:10.1016\/j.cct.2009.03.001)","volume":"30","author":"Blasey","year":"2009","journal-title":"Contemporary clinical trials"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cct.2009.03.001","article-title":"A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction","volume":"30","author":"Blasey","year":"2009","journal-title":"Contemporary Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/JCP.0b013e3182239191","article-title":"Efficacy and safety of mifepristone for the treatment of psychotic depression","volume":"31","author":"Blasey","year":"2011","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-2007-1017421","article-title":"A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor","volume":"17","author":"Casacchia","year":"1984","journal-title":"Pharmacopsychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004044.pub3-BIB34|cit34","first-page":"395","article-title":"A comparison of phenelzine and imipramine in depressed inpatients","volume":"42","author":"Davidson","year":"1981","journal-title":"Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD004044.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.biopsych.2006.05.034","article-title":"Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression","volume":"15","author":"DeBattista","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004044.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004714-199704000-00018","article-title":"Lithium-TCA combination treatment of psychotic depression: comparison with TCA-neuroleptic treatment","volume":"17","author":"Ebert","year":"1997","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.npp.1300884","article-title":"Clinical and biological effects of mifepristone treatment for psychotic depression","volume":"31","author":"Flores","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004044.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0022-3956(66)90012-4","article-title":"Imipramine (Tofranil vs. placebo in hospitalized psychotic depressives. (a comparison of patients' self-ratings, psychiatrists' ratings and psychological test scores)","volume":"4","author":"Friedman","year":"1966","journal-title":"Journal of Psychiatric Research"},{"issue":"7","key":"10.1002\/14651858.CD004044.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jpsychires.2008.10.004","article-title":"Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol - a double-blind multicenter trial","volume":"43","author":"K\u00fcnzel","year":"2009","journal-title":"Journal of Psychiatric Research"},{"issue":"5","key":"10.1002\/14651858.CD004044.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00004714-199910000-00011","article-title":"Limited efficacy of ketoconazole in treatment-refractory major depression","volume":"19","author":"Malison","year":"1999","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD004044.pub3-BIB41|cit41","first-page":"85","article-title":"Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study)","volume":"30","author":"McLaughlin","year":"1969","journal-title":"Diseases of the Nervous System"},{"issue":"2","key":"10.1002\/14651858.CD004044.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004714-199804000-00003","article-title":"Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome","volume":"18","author":"Muller-Siecheneder","year":"1998","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD004044.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1034\/j.1600-0447.2001.00228.x","article-title":"Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study","volume":"103","author":"Navarro","year":"2001","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3-4","key":"10.1002\/14651858.CD004044.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0165-0327(84)80008-7","article-title":"Phenomenology, neuroendocrine function, and tricyclic antidepressant response","volume":"6","author":"Nelson","year":"1984","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub3-BIB45|cit45","first-page":"184","article-title":"Pharmacological treatment of delusional depressives","volume":"18","author":"Spiker","year":"1982","journal-title":"Psychopharmacology Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD004044.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00004714-199812000-00004","article-title":"Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study","volume":"18","author":"Zanardi","year":"1998","journal-title":"Journal of Clinical Psychopharmacology."},{"key":"10.1002\/14651858.CD004044.pub3-BIB47|cit47","volume-title":"Cochrane Reviewer's Handbook 4.2.2","author":"Alderson","year":"2004"},{"key":"10.1002\/14651858.CD004044.pub3-BIB48|cit48","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III), 3rd edition","year":"1980"},{"key":"10.1002\/14651858.CD004044.pub3-BIB49|cit49","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R), 3rd edition","year":"1987"},{"key":"10.1002\/14651858.CD004044.pub3-BIB50|cit50","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edition","year":"1994"},{"key":"10.1002\/14651858.CD004044.pub3-BIB51|cit51","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR)","year":"2000"},{"key":"10.1002\/14651858.CD004044.pub3-BIB52|cit52","volume-title":"Practice Guideline for the Treatment of Patients With Major Depressive Disorder (revision)","year":"2010"},{"issue":"9","key":"10.1002\/14651858.CD004044.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00005053-198409000-00002","article-title":"The clinical and neuroendocrine features of psychotic depression","volume":"172","author":"Coryell","year":"1984","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD004044.pub3-BIB54|cit54","first-page":"22","article-title":"The treatment of psychotic depression","volume":"59(Suppl 1)","author":"Coryell","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD004044.pub3-BIB56|cit56","unstructured":"Trimbos CBO NHG LEVV NVvP NIP Dutch Multidisciplinairy Guideline for Depression 2009"},{"key":"10.1002\/14651858.CD004044.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4088\/JCP.11r07324","article-title":"Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment","volume":"73","author":"Farahani","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub3-BIB58|cit58","doi-asserted-by":"crossref","unstructured":"Guy W Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology, revised National Institute of Mental Health, Rockville, MD 1976","DOI":"10.1037\/e591322011-001"},{"key":"10.1002\/14651858.CD004044.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurological and Neurosurgical Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub3-BIB60|cit60","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"12","key":"10.1002\/14651858.CD004044.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archpsyc.1991.01810360039006","article-title":"The validity of major depression with psychotic features based on a community study","volume":"48","author":"Johnson","year":"1991","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004044.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0447.2008.01237.x","article-title":"Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration","volume":"118","author":"Licht","year":"2008","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004044.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0447.2009.01382.x","article-title":"Clinical practice recommendations for depression","volume":"119","author":"Mahli","year":"2009","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004044.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004044.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00023210-199708060-00004","article-title":"Psychotic depression a guide to drug choice","volume":"8","author":"Nelson","year":"1997","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD004044.pub3-BIB66|cit66","volume-title":"The treatment and management of depression in adults (updated version). National Clinical Practice Guideline 90","year":"2009"},{"issue":"11","key":"10.1002\/14651858.CD004044.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1176\/appi.ajp.159.11.1855","article-title":"Prevalence of depressive episodes with psychotic features in the general population","volume":"159","author":"Ohayon","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004044.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-0327(92)90056-C","article-title":"Psychotic (delusional) depression: a meta-analysis of physical treatments","volume":"24","author":"Parker","year":"1992","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0165-1781(90)90098-P","article-title":"Medication resistance and clinical response to electroconvulsive therapy","volume":"31","author":"Prudic","year":"1990","journal-title":"Psychiatry Research"},{"issue":"8","key":"10.1002\/14651858.CD004044.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1176\/ajp.153.8.985","article-title":"Resistance to antidepressant medications and short-term clinical response to ECT","volume":"153","author":"Prudic","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub3-BIB71|cit71","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"key":"10.1002\/14651858.CD004044.pub3-BIB72|cit72","first-page":"10","article-title":"The definition and meaning of treatment-resistant depression","volume":"62(Suppl 16)","author":"Sackeim","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub3-BIB73|cit73","volume-title":"Comrehensive Textbook of Psychiatry","author":"Sadock","year":"2009"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub3-BIB74|cit74","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.jcp.0000130551.70878.56","article-title":"Effect of antidepressant medication resistance on short-term response to ECT","volume":"24","author":"Broek","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD004044.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00004714-200010000-00003","article-title":"Somatic treatment of psychotic depression: review and recommendations for practice","volume":"20","author":"Wheeler Vega","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004044.pub3-BIB76|cit76","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004044.pub2","article-title":"Pharmacological treatment for psychotic depression","author":"Wijkstra","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004044.pub3-BIB77|cit77","first-page":"1","article-title":"Treatment of unipolar psychotic depression: the use of evidence in practice guideline","volume":"24","author":"Wijkstra","year":"2007","journal-title":"World Journal of Biological Psychiatry"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004044.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004044.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:29:27Z","timestamp":1628544567000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004044.pub3"}},"subtitle":[],"editor":[{"given":"Jaap","family":"Wijkstra","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,26]]},"references-count":77,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004044.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004044.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2013,11,26]]}}}